Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

[Use of crizotinib for refractory ALK-positive lymphomas].

Shelikhova LN, Fominykh VV, Abramov DS, Myakova NV, Maschan MA, Maschan AA.

Ter Arkh. 2017;89(7):51-56. doi: 10.17116/terarkh201789751-56. Russian.

PMID:
28766541
2.

Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study.

Samochatova EV, Maschan AA, Shelikhova LN, Myakova NV, Belogurova MB, Khlebnikova OP, Shamardina AV, Ryskal OV, Roumiantseva JV, Konovalov DM, Dubrovina ME, Rumyantsev AG.

J Pediatr Hematol Oncol. 2014 Jul;36(5):395-401. doi: 10.1097/MPH.0b013e31829d4900.

PMID:
23823112

Supplemental Content

Loading ...
Support Center